Get started
Author

Yilun Qu

Direct pharmacological targeting of Piezo1 by Paeoniflorin: a novel therapeutic approach for renal fibrosis
2025 · Run Li, Jikai Xia, et al. · Journal of Advanced Research · 20
Oleanolic acid and its analogues: promising therapeutics for kidney disease
2024 · Dan Pan, Yilun Qu, et al. · Chinese Medicine · 16
The therapeutic effect of Shenhua tablet against mesangial cell proliferation and renal inflammation in mesangial proliferative glomerulonephritis
2023 · Jiayi He, Fei Peng, et al. · Biomedicine & Pharmacotherapy · 16
SOCS1 Peptidomimetic Alleviates Glomerular Inflammation in MsPGN by Inhibiting Macrophage M1 Polarization
2023 · Yinghua Zhao, Fei Peng, et al. · Inflammation · 13
Oleanolic acid inhibits mesangial cell proliferation and inflammatory response in mesangial proliferative glomerulonephritis through IL-17/ERK/AKT pathway
2025 · Dan Pan, Jikai Xia, et al. · International Immunopharmacology · 8
IKZF1 as a potential therapeutic target for dendritic cell-mediated immunotherapy in IgA nephropathy
2025 · Fei Peng, Chunjia Sheng, et al. · Cell Communication and Signaling · 5
Paeoniflorin Attenuates the Progression of Diabetic Kidney Disease by Regulating Macrophage Differentiation
2025 · Chunru Shi, Run Li, et al. · Phytotherapy Research · 3
Distribution of Traditional Chinese Medicine syndromes in diabetic kidney disease chronic kidney disease 1-5: a correlation study.
2024 · L I Shuang, Duan Shuwei, et al. · PubMed · 3
PDF
Dysregulation of argininosuccinate synthase 1, phosphoenolpyruvate carboxykinase 1, and carbonyl reductase 3: Key arginine–proline metabolic mediators in mesangioproliferative glomerulopathies
2025 · Jiayi He, Fei Peng, et al. · International Journal of Biological Macromolecules · 2
Relationship between Traditional Chinese Medicine Syndrome Elements and Prognosis of Patients with IgA Nephropathy
2022 · Jianghua Ke, Shuwei Duan, et al. · Evidence-based Complementary and Alternative Medicine · 2
PDF
Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies
2026 · Ziyue Zhang, Yilun Qu, et al. · Research · 1
Correction to: SOCS1 Peptidomimetic Alleviates Glomerular Inflammation in MsPGN by Inhibiting Macrophage M1 Polarization
2023 · Yinghua Zhao, Fei Peng, et al. · Inflammation · 1
PDF
Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine
2022 · Yi-lun Qu, Zhe-yi Dong, et al. · Chinese Journal of Integrative Medicine · 1
Bim Inhibition Ameliorates Visual Loss and Promotes Axon Regeneration by Up-Regulation of Drd1 Expression
2026 · Zhenhao Cheng, Lingling Wu, et al. · American Journal Of Pathology
Traditional Chinese Medicine related factors of planned dialysis in chronic kidney disease stage 5 patients with type 2 diabetes mellitus: a multicenter cross-sectional study.
2026 · Zhang Ruimin, L I Shuang, et al. · PubMed
Direct pharmacological targeting of RAC1 by chlorogenic acid: A novel therapeutic approach for mesangial proliferative glomerulonephritis
2026 · Yilun Qu, Lingling Wu, et al. · Acta Pharmaceutica Sinica B
Targeting the gut‒kidney axis for lupus nephritis treatment: multimechanism regulatory strategies and evidence from Traditional Chinese medicine
2026 · Qingyun Fang, Jiabao Liu, et al. · Chinese Medicine
PDF
Noninvasive identificational diagnosis of diabetic nephropathy and non-diabetic renal disease based on clinical characteristics of Traditional Chinese Medicine symptom pattern and conventional medicine.
2023 · Q U Yilun, Cheng Haimei, et al. · PubMed
PDF
Works count: 18
Citation count: 91
H-index: 5
I10-index: 4
Year
Topic
Type